Q1 2025 Cibus Inc Earnings Call Transcript

May 8, 2025 / 08:30 PM GMT

Release Date Price: $2.35 (-6.00%)

Transcript 10-Q8-K

Key Points

Positve

Cibus Inc (CBUS) has demonstrated clear validation of its commercial strategy and the transformative potential of its RTDS technology platform.
The company has secured agreements with major rice seed companies, representing approximately 40% of accessible rice acres across North and Latin America.
Cibus Inc (CBUS) achieved a significant milestone with field trial results for stacked, gene-edited, herbicide tolerance traits in rice.
The company has made progress in disease resistance traits, particularly in canola, with multiple modes of action for sclerotonia resistance.
Cibus Inc (CBUS) has advanced its bio-based fermentation bio fragrance products, anticipating commercialization agreements with consumer packaged goods partners this year.

Negative

Cibus Inc (CBUS) reported a net loss of $49.4 million for the first quarter of 2025, compared to a net loss of $27 million in the year-ago period.
The increase in net loss was primarily due to a $21 million non-cash goodwill impairment recorded in the first quarter of 2025.
General and administrative expenses increased to $9.9 million for the first quarter of 2025, primarily due to a $3 million litigation accrual.
The company's cash and cash equivalents are expected to fund planned operating expenses only into the third quarter of 2025.
Cibus Inc (CBUS) is focused on significantly reducing its cash burn rate in 2025, indicating financial constraints.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CBUS.OQ - Cibus Inc
Q1 2025 Cibus Inc Earnings Call
May 08, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to the CBS 125 earnings call. All participants will be in a listen-only mode. After today's presentation, there will be an opportunity to ask questions. Please also note today's event is being recorded.

At this time, I'd like to turn the conference over to Carlo Bruce, interim Chief Financial Officer. Sir, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you and good afternoon. I would like to thank you for taking time to join us for CIA's first quarter 2025 financial results and business conference call and webcast. Presenting with me today is

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.